🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It's #LungCancerAwarenessMonth. For information on #lungcancer including risk factors, symptoms & treatment visit: lung-cancer.canceraustralia.gov.au

Lung cancer is the leading cause of cancer death in women. Don't ignore the signs! Thanks for coming on the journey with us this #LungCancerAwarenessMonth Find out more > buff.ly/3Ost4Pk #LCAM

Really important for referring clinicians to be aware of #SABR as non-invasive safe & effective Rx for early stage lung cancer. Patients with comorbidities or poor pulmonary fxn should not be precluded from screening RACGP Cancer Australia Cancer Institute NSW A/Prof Nicole Rankin

Targeting Cancer nails it again - a compelling story about the ease of curing #lungcancer with SABR! 👀- youtu.be/5duUY1kB_kw?si… SABR EGFR Resisters Julie McCrossin AM (She/Her) Jill Feldman LUNGevity Foundation Chris Draft Lung Foundation Australia

Angeline Low is not just a survivor—she’s a powerful voice for lung cancer awareness and advocacy! In her heartfelt message, she proclaims, “I’m alive! Thank you.” Angeline's journey highlights the resilience and strength of those affected by lung cancer, reminding us all of the

Medical mistrust is a barrier to #lungcancer screening regardless of race in 🇺🇸Food for thought with upcoming #lungcancer screening in 🇦🇺⁦Cancer Australia⁩ ⁦A/Prof Nicole Rankin⁩ tandfonline.com/doi/full/10.10…

RWD from 🇨🇳on the % of unresectable patients with St III NSCLC whose cancers become resectable post chemoIO. 30% of cancers remain unresectable! Caution advised on using neoadjuvant approach for these cases. Drew Moghanaki Brendon Stiles sciencedirect.com/science/articl…

Thought provoking Danish study. MDTs cornerstone of oncology Rx esp #lungcancer. Dist’n of 60 fictitious cases shows poor agreement on stage & Rx intent esp St III NSCLC. Urgent need for #quality indicators to measure process & outcomes ⁦LUCAP Australia⁩ bmccancer.biomedcentral.com/articles/10.11…

👏🏽👏🏽👏🏽 Nicole Knox on 1st PhD pub. Examining unmet needs in older adults with lung cancer Nicole Knox Meera agar Prof Louise Hickman sciencedirect.com/science/articl…

🙏🏽 IASLC for showcasing our nurse led geriatric oncology model of care for older patients with #lungcancer. Study Demonstrates Multidisciplinary Approach Can Improve Care for Elderly Lung Cancer Patients ilcn.org/study-demonstr… Nicole Knox Meera agar Prof Louise Hickman

Our comprehensive assessment of NCI cooperative group trials is out in JNCI! If you are involved or enrolling in coop trials, please consider reading. A 🧵of our major findings. 1/12 academic.oup.com/jnci/advance-a…

Why is radiation held to a higher standard than drugs??

Lung cancer breakthroughs made 2024 one of the most consequential years for lung cancer researchers and clinicians. Join hosts Narjust Florez, MD, FASCO & Stephen V Liu, MD as they review the significant clinical trials from 2024. ➡️ @https://bit.ly/LCC2024 IASLC Thoracic Oncology Group of Australasia

Radiation Oncology is characterized by rapid innovation Dissemination & implementation are important aspects to bring this progress to our cancer patients in daily practice Well written review by Erin Gillespie, MD MPH and colleagues 👇 redjournal.org/article/S0360-…

I think everyone should read this review of radiotherapy vs systemic trials and endpoints selected. Why is the world focused on omitting RT and not reducing systemic Tx? Matthias Guckenberger Icro Meattini

Thoracic RadOncs should check out our paper in this month's Clinical Oncology pubmed.ncbi.nlm.nih.gov/39317606/ We worked with the International Cardio-Oncology Society to develop a survey for stock-taking practice in lung cancer radiotherapy & to identify key gaps & solutions

Remember the misleading press reports about "brutal" #radonc after PROSPECT ? This is what modern radiotherapy can achieve for elderly breast cancer patients! 👉 "Endocrine Tx was associated with a greater reduction in HRQOL compared with RT at 24 mo" 👉 oncological data awaited

👏🏽👏🏽👏🏽Amazing to see incorporation of frailty screening (G8) in assessment & reporting. Should be standard for all #clinicaltrials recruiting older people. SIOG

Online First: New Research: Global #LINAC requirements and personalised country recommendations: a cross-sectional, population-based study thelancet.com/journals/lanon…

Time for a RCT comparing hypofractionation 55/20 vs conventional fractionation 60/30 for Stage III NSCLC? onlinelibrary.wiley.com/doi/10.1111/aj… Yu Yang Soon Eric Hau RadOncResearch Trans Tasman Radiation Oncology Group Any 🇦🇺 med oncs interested in joining our team?